<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The outcome of patients with <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PHT</z:e>) and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) is usually fatal </plain></SENT>
<SENT sid="1" pm="."><plain>The authors report the rare case of a patient with primary APS and nonthrombotic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PHT</z:e> who has survived for twenty years after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PHT</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In this case, the patient's <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PHT</z:e> resembled the primary idiopathic variety with clear lung fields and <z:mpath ids='MPATH_458'>normal</z:mpath> perfusion on the lung scan, and the combination therapy with nitrate, digoxin, and <z:chebi fb="40" ids="35498">diuretics</z:chebi> had been performed </plain></SENT>
<SENT sid="3" pm="."><plain>During her clinical course over twenty years, she had not experienced any critical pulmonary <z:mp ids='MP_0005048'>thrombosis</z:mp> that influenced the progression of nonthrombotic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PHT</z:e> or any other severe systemic involvement of APS </plain></SENT>
</text></document>